Source link : https://www.yourblogdomain.com/2024/12/13/europe-approves-its-first-drug-for-von-hippel-lindau-tumors/
Source link : https://www.newshealth.biz/health-news/europe-approves-its-first-drug-for-von-hippel-lindau-tumors/ The European Medicines Agency (EMA) has recommended that a new oral agent, Welireg (belzutifan), be granted conditional marketing authorization for treatment of two different diseases: the rare genetic disorder von Hippel-Lindau disease (VHL) and a type of advanced renal cell carcinoma often featuring the same gene fault. Welireg represents the first […]
Author : yourblogdomain
Publish date : 2024-12-13 17:02:57
Copyright for syndicated content belongs to the linked Source.